Opioid related deaths in England and Wales are considerably higher than the OECD average. Addressing opioid dependence, misuse and overdoses in the UK requires policy coordination across health, social and criminal justice systems (CDPRG)
Bibliography: Domestic Policy Issues
National intelligence network on drug health harms briefing: August 2019
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (PHE)
Assessing Cannabis Supply and Demand in Washington State
This report provides detailed information about state-legal cannabis production and sales in Washington, as well as insights about the total amount of tetrahydrocannabinol (THC) obtained from legal and illegal sources by Washington residents (RAND)
Australian NSP Survey National Data Report 2014 – 2018
The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (antibody and RNA) and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia
Drug-related Deaths in Scotland in 2018
Statistics of drug-related deaths in 2018 and earlier years, broken down by cause of death, selected drugs reported, age and sex (National Records of Scotland)
Drugs policy: medicinal cannabis
Contents section (Parliament, UK)
Stronger evidence needed to improve confidence in medicinal cannabis
Despite the rescheduling of medicinal cannabis, very few prescriptions have been issued. One of the many reasons for this is because of the gaps in the evidence base (Parliament, UK)
Breaking the embargo: a proposal to break UK public health medicinal cannabis impasse (PDF)
Commissioning national clinical assessments of cannabis-based medicinal products in the management of chronic disease (Centre for Medicinal Cannabis)
Hard Edges
The central aim of this study was to establish a statistical profile of the extent and nature of severe and multiple disadvantage (SMD) in Scotland
Report into homelessness and drug misuse published
Safe housing key to tackling homeless drug misuse, says ACMD report
Cannabis-based products for medicinal use
In development [GID-NG10124] Expected publication date: 21 October 2019 (NICE)
Drug and alcohol services: an update
This paper provides an overview of the current position of drug and alcohol services in Scotland and summarises the progress against recommendations made in our 2009 report (Audit Scotland)
Drugs policy inquiry – publications
Inquiry launched on Monday 4 February 2019. The closing date for written submissions was Monday 18 March 2019 (Parliament UK)
Misuse of illicit drugs and medicines: applying All Our Health
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm (Public Health England)
Alcohol and other drug treatment services in Australia 2017–18: key findings
In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol (34% of all treatment episodes), amphetamines (25%), cannabis (21%) and heroin (5%). Two-thirds (66%) of all clients receiving treatment were male and the median age of clients was 34 years (AIHW)
Cannabis policy and legislation in the Nordic countries
The Nordic Welfare Centre´s new report Cannabis policy and legislation in the Nordic countries looks at the similarities and differences in legislation and the ways in which the law is enacted in legal practice, police work, and other arenas
National Prison Drugs Strategy
Ministry of Justice and Her Majesty’s Prison and Probation Service Prison Drugs Strategy
Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971
This circular draws attention to the contents of the below Statutory Instruments (SIs), S.I. 2018/1356 and 2018/1383, which will come into force at 00.01 on 1 April 2019 (Home Office)
Supervised Drug Consumption Facilities Bill
1 Safe drug consumption facilities
2 Licence for provision of safe drug consumption facilities
3 Amendments to the Misuse of Drugs Act 1971
4 Annual report
5 Regulations
6 Financial provisions
7 Extent, commencement and short title
DrugScope Library Wellcome
This is a collection of grey literature and some archive material relating to drugs and drug policy, originally part of the library holdings at DrugScope (Wellcome)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 17
- Next Page »
